“You have a pattern of inattention to human subjects protection requirements.”
— Kaiser Permanente’s Institutional Review Board, an independent committee required by law to ensure patient safety in clinical studies, to two Kaiser researchers whose test of a fish-oil derived drug’s effectiveness in treating respiratory illnesses was halted after an audit found some patients being tested had shellfish allergies and weren’t excluded, putting them at risk.
News Summary:
- Failing to protect patients in treatment test
- Check all news and articles from the latest Health updates.
- Please Subscribe us at Google News.
Denial of responsibility! Neefina is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email: [email protected] The content will be deleted within 24 hours.